Treatment of multiple myeloma patients with autologous stem cell transplantation — a fresh analysis

Treatment of multiple myeloma patients with autologous stem cell transplantation — a fresh analysis

Patients with multiple myeloma (MM) treated with conventional chemotherapy have an averagesurvival of approximately three years. High dose chemotherapy followed by autologous stem cell transplantation(ASCT), first introduced in the mid-1980s, is now considered the standard therapy for almost all pat...

Full description

Bibliographic Details
Main Authors: Malgorzata Wach, Maria Cioch, Marek Hus, Dariusz Jawniak, Wojciech Legiec, Magdalena Malek, Joanna Manko, Adam Walter-Croneck, Ewa Wasik-Szczepanek, Anna Dmoszynska
Format: Article
Language:English
Published: Via Medica 2011-07-01
Series:Folia Histochemica et Cytobiologica
Subjects:
multiple myeloma
high dose chemotherapy
autologous peripheral blood stem cell transplantation
Online Access:http://www.fhc.viamedica.pl/darmowy_pdf.phtml?indeks=2&indeks_art=1588

Internet

http://www.fhc.viamedica.pl/darmowy_pdf.phtml?indeks=2&indeks_art=1588

Similar Items